CPT2 Recombinant monoclonal antibody, PBS Only 85013-4-PBS proteintech

$699.00
In stock
SKU
85013-4-PBS
Catalog No.SizePrice (USD)
85013-4-PBS-100UG100 μg$699.00
Catalog Number85013-4-PBS
Synonyms242381C5, Carnitine O-palmitoyltransferase 2, mitochondrial, carnitine palmitoyltransferase 2, CPT II, CPTASE
HostRabbit
Reactivityhuman, mouse, rat
FormLiquid
FormulationPBS Only
ApplicationsWB, IHC, Indirect ELISA
Host / IsotypeRabbit / IgG
Tested Reactivityhuman, mouse, rat
ClassRecombinant
TypeAntibody
ImmunogenCatNo: Ag24897 Product name: Recombinant human CPT2 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 32-178 aa of BC002445 Sequence: GQYLQRSIVPTMHYQDSLPRLPIPKLEDTIRRYLSAQKPLLNDGQFRKTEQFCKSFENGIGKELHEQLVALDKQNKHTSYILGPWFDMYLSARDSVVLNFNPFMAFNPDPKSEYNDQLTRATNMTVSAIRFLKTLRAGLLEPEVFHL Predict reactive species
Full Namecarnitine palmitoyltransferase 2
Calculated Molecular Weight74 kDa
Observed Molecular Weight65-70 kDa
GenBank Accession NumberBC002445
Gene SymbolCPT2
Gene ID (NCBI)1376
RRIDAB_3743938
ConjugateUnconjugated
Purification MethodProtein A purfication
UNIPROT IDP23786
Storage BufferPBS only, pH 7.3.
Storage ConditionsStore at -80°C.
Citations-
IsotypeIgG
ClonalityRecombinant
Clone Number242381C5
ConjugationUnconjugated

Carnitine palmitoyltransferase-1 and -2 (CPT1 and CPT2) are two genetically distinct mitochondrial membrane bound enzymes and play critical role in the regulation of FAO in normal cells. CPT2 is an ubiquitous protein and locates in the inner membrane of mitochondrial (PMID: 29437870). CPT2 is frequently down-regulated in primary ovarian serous carcinomas, which is significantly correlated with poor survival of ovarian cancer patients (PMID: 33486313). Down-regulation of CPT2 was a major cause of acylcarnitine accumulation and a common feature in mouse models of obesity- and NASH-driven HCC and human SH-HCC (PMID: 29872321).

Reviews

Write Your Own Review
You're reviewing:CPT2 Recombinant monoclonal antibody, PBS Only 85013-4-PBS proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.